unknown
Stage
About
Dialybrid develops and commercializes hybrid arteriovenous vascular grafts for hemodialysis using a proprietary Silkothane® technology combining silk fibroin and polyurethane.
Explore Dialybrid's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.